Robert L. Coleman, MD is professor of gynecologic oncology and vice-chair of clinical research at The University of Texas MD Anderson Cancer Center in Houston, Texas.
Dr. Coleman’s research interests include novel therapeutics for ovarian, uterine, and cervical cancer, clinical trial development and statistical design, surgical innovations, and graduate education.
Dr. Coleman has authored or coauthored over 400 scientific publications, including over 188 peer-reviewed articles, numerous book chapters, monographs, invited articles and textbooks including, The Handbook of Gynecologic Oncology, Clinical Lymphatic Mapping in Gynecologic Cancers, Prognostic and Predictive Factors in Gynecological Cancers, and Atlas of Gynecologic Oncology.
In 2012, Dr. Coleman was elected to the position of Secretary Treasurer for the International Gynecologic Cancer Society, and was Program Chair for the 2012 biannual meeting. He currently sits on the American Board of Obstetrics and Gynecology, Division of Gynecologic Oncology. He has served on the Board of Directors for the Foundation for Women’s Cancer (formerly, the Gynecologic Cancer Foundation) and serves on the Council of the Society of Gynecologic Oncologists. In June 2010 he was appointed to the Ann Rife Cox Chair in Gynecology and is a member of the MDACC Center for RNA Interference and Non-Coding RNA. In 2013, Dr. Coleman was elected to serve as President Elect II on the Society of Gynecologic Oncology Board of Directors.